US BioTec Inc (USBC) financials · $160.8M cap
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
US BioTec Inc (USBC) $160.8M cap.
| Line | FY2025 | FY2024 | Pro (2 older periods with Lician Pro) |
|---|---|---|---|
| Operating Income | −$18.05M | −$15.22M | |
| Net Income | −$22.12M | −$16.58M | |
| EPS (Diluted) | −$0.39 | −$7.85 | |
| Unlock 5 years of statements: Lician Pro $149/yr | |||
| Line | FY2025 | FY2024 | Pro (3 older periods with Lician Pro) |
|---|---|---|---|
| Total Assets | $93.67M | $3.66M | |
| Current Assets | $6.79M | $3.11M | |
| Cash & Equivalents | $4.10M | $3.11M | |
| PP&E | $28.55K | $66.80K | |
| Total Liabilities | $12.14M | $5.82M | |
| Current Liabilities | $3.68M | $5.16M | |
| Shareholders' Equity | $81.53M | −$2.16M | |
| Retained Earnings | −$190.55M | −$138.74M |
| Line | FY2025 | FY2024 | Pro (3 older periods with Lician Pro) |
|---|---|---|---|
| Operating Cash Flow | −$4.63M | −$12.83M | |
| CapEx | — | $66.35K | |
| Investing Cash Flow | — | −$66.35K | |
| Financing Cash Flow | −$99.50K | $7.98M | |
| Free Cash Flow | −$4.63M | −$12.90M |
Source: Company filings with the SEC (EDGAR) · Latest period FY2025
FAQ
What is USBC P/E and revenue?
US BioTec Inc (USBC) $160.8M cap.
What is USBC revenue?
USBC income-statement cache has no revenue figure yet.
Is USBC profitable?
US BioTec Inc last cached net income is -$22.1M (FY2025).
What are USBC total assets?
US BioTec Inc last cached total assets are $93.7M (FY2025).
What is USBC free cash flow?
US BioTec Inc last cached free cash flow is -$4.63M (FY2025).
Not investment advice. Figures as reported in company filings, not a live feed.